secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2023-07-12T23:59:59+00:00
Accession:  0000914475-23-000047
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine appoints Christine Poon to board; bylaws amended to increase board to 10
--------------------------------------------------------------------------------

- Christine A. Poon appointed as Class I director effective July 11, 2023, term until 2024 annual meeting.
- Poon receives $60k annual cash retainer and option for 16,375 shares (~$800k Black-Scholes) vesting over 3 years.
- Board size increased from 9 to 10 via amendment to Section 3.2 of Bylaws.
- Poon previously served as Vice Chairman of Johnson & Johnson and Dean at Ohio State Fisher College of Business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447523000047/0000914475-23-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447523000047/nbix-20230711.htm
  HTML page:      https://secwatch.observer/filing/0000914475-23-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer